Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells
Open Access
- 5 February 2010
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 33
Abstract
Background: Heparanase facilitates the invasion and metastasis of cancer cells, and is over-expressed in many kinds of malignancies. Our studies indicated that heparanase was frequently expressed in advanced gastric cancers. The aim of this study is to determine whether silencing of heparanase expression can abolish the malignant characteristics of gastric cancer cells. Methods: Three heparanase-specific small interfering RNA (siRNAs) were designed, synthesized, and transfected into cultured gastric cancer cell line SGC-7901. Heparanase expression was measured by RT-PCR, real-time quantitative PCR and Western blot. Cell proliferation was detected by MTT colorimetry and colony formation assay. The in vitro invasion and metastasis of cancer cells were measured by cell adhesion assay, scratch assay and matrigel invasion assay. The angiogenesis capabilities of cancer cells were measured by tube formation of endothelial cells. Results: Transfection of siRNA against 1496-1514 bp of encoding regions resulted in reduced expression of heparanase, which started at 24 hrs and lasted for 120 hrs post-transfection. The siRNA-mediated silencing of heparanase suppressed the cellular proliferation of SGC-7901 cells. In addition, the in vitro invasion and metastasis of cancer cells were attenuated after knock-down of heparanase. Moreover, transfection of heparanase-specific siRNA attenuated the in vitro angiogenesis of cancer cells in a dose-dependent manner. Conclusions: These results demonstrated that gene silencing of heparanase can efficiently abolish the proliferation, invasion, metastasis and angiogenesis of human gastric cancer cells in vitro, suggesting that heparanase-specific siRNA is of potential values as a novel therapeutic agent for human gastric cancer.Keywords
This publication has 52 references indexed in Scilit:
- In silico selection of active siRNADrug Discovery Today, 2007
- Local RNA Target Structure Influences siRNA Efficacy: Systematic Analysis of Intentionally Designed Binding RegionsJournal of Molecular Biology, 2005
- A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann NephritisJournal of the American Society of Nephrology, 2004
- The gene-silencing efficiency of siRNA is strongly dependent on the local structure of mRNA at the targeted regionBiochemical and Biophysical Research Communications, 2004
- Functional siRNAs and miRNAs Exhibit Strand BiasCell, 2003
- Asymmetry in the Assembly of the RNAi Enzyme ComplexCell, 2003
- Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal developmentSeminars in Cancer Biology, 2002
- Heparanase as mediator of angiogenesis: mode of actionThe FASEB Journal, 2001
- Cloning and Expression Profiling of Hpa2, a Novel Mammalian Heparanase Family MemberBiochemical and Biophysical Research Communications, 2000
- Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structureJournal of Molecular Biology, 1999